Skip to main content

Gold Mitchell's Form 4 filing

Alpine Immune Sciences, Inc. (ALPN) · filed Dec 12, 2023

Accession no.
0001626199-23-000134
Filed
Dec 12, 2023, 9:02 PM ET
Trade date
Dec 8-12, 2023
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.04M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Gold MitchellCIK 0001242882Director, Officer (Executive Chairman and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 8, 2023Common StockSSaleDisposed−8,067$17.08F2−$137,783.55101,320Direct
Dec 11, 2023Common StockSSaleDisposed−68,870$17.26F3−$1,189,026.7832,450Direct
Dec 12, 2023Common StockSSaleDisposed−32,450$17.32F4−$561,887.980Direct
Dec 12, 2023Common StockMOption exerciseAcquired+8,613$0.45+$3,875.858,613Direct
Dec 12, 2023Common StockSSaleDisposed−8,613$17.32F4−$149,138.40Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 12, 2023Common StockMOption exerciseDisposed−8,613$0.00$042,629Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $17.00 to $17.25. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $17.00 to $17.75. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $17.00 to $17.56. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)